Daniel Salain - 28 Sep 2022 Form 3 Insider Report for IDERA PHARMACEUTICALS, INC.

Role
Chief Operating Officer
Signature
/s/ John J. Kirby, Attorney-in-Fact for Daniel Salain
Issuer symbol
N/A
Transactions as of
28 Sep 2022
Net transactions value
$0
Form type
3
Filing time
30 Sep 2022, 21:44:10 UTC
Next filing
19 Jan 2023
SEC
View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney